Evidence map›Paper›PMID 35814124›Full record

ArticleFrontiers in psychology2022

Validation of the Japanese Big Five Scale Short Form in a University Student Sample.

Rie Toyomoto, Masatsugu Sakata, Kazufumi Yoshida, Yan Luo, Yukako Nakagami, Taku Iwami, Shuntaro Aoki, Tomonari Irie, Yuji Sakano, Hidemichi Suga and 7 more

Abstract read
In one paragraph

Article in Frontiers in psychology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Rie ToyomotoDepartment of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Masatsugu SakataDepartment of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kazufumi YoshidaDepartment of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Yan LuoDepartment of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Yukako NakagamiAgency for Health, Safety and Environment, Kyoto University Health Service, Kyoto, Japan.
Taku IwamiAgency for Health, Safety and Environment, Kyoto University Health Service, Kyoto, Japan.
Shuntaro AokiCenter for Medical Education and Career Development, Fukushima Medical University, Fukushima, Japan.
Tomonari IrieDepartment of Psychology and Counseling, School of Education and Culture, Hokusho University, Ebetsu, Japan.
Yuji SakanoDepartment of Clinical Psychology, Goryokai Medical Corporation, Sapporo, Japan.
Hidemichi SugaDepartment of Social Welfare, Ryukoku University Junior College, Kyoto, Japan.
Michihisa SumiRitsumeikan Medical Service Center, Kyoto, Japan.
Hiroshi IchikawaDepartment of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan.
Takafumi WatanabeDepartment of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Science, Nagoya, Japan.
Aran TajikaDepartment of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Teruhisa UwatokoDepartment of Psychiatry, Kyoto University Hospital, Kyoto, Japan.
Ethan SahkerDepartment of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Toshi A FurukawaDepartment of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Japanese Big Five Scale Short Form (JBFS-SF), a 29-item self-report scale, has recently been used to measure the Big Five personality traits. However, the scale lacks psychometric validation. This study examined the validity and reliability of the JBFS-SF with data collected from 1,626 Japanese university students participating in a randomized controlled clinical trial. Structural validity was tested with exploratory and confirmatory factor analysis and measurement invariance tests were conducted across sex. Internal consistency was evaluated with McDonald's omega. Additionally, construct validity was estimated across factors using the PHQ-9, GAD-7, AQ-J-10, and SSQ. EFA results showed that the JBFS-SF can be classified according to the expected five-factor structure, while three items had small loadings. Therefore, we dropped these three items and tested the reliability and validity of the 26-item version. CFA results found that a 26-item JBFS-FS has adequate structural validity (GFI = 0.907, AGFI = 0.886, CFI = 0.907, and RMSEA = 0.057). The omega of each factor was 0.74-0.85. Each JBFS-SF factor was specifically correlated with the PHQ-9, GAD-7, and SSQ. This research has shown that the JBFS-SF can be a clinically useful measure for assessing personality characteristics.

Indexed as

adolescencebrief measuresfive-factor modelpersonalitypsychometric properties

Identifiers

PMID35814124
PMCPMC9262100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.